Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
The Journal of Experimental Medicine
|
March 18, 2024
Competitive fungal commensalism mitigates candidiasis pathology
Jarmila Sekeresova Kralova, Catalina Donic, Bareket Dassa, et al.
Nature Cancer
|
February 5, 2022
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
Adi Jacob Berger, Elinor Gigi, Lana Kupershmidt, et al.
Cell
|
September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.
Nature Cancer
|
February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Nancy Gavert, Yaara Zwang, Roi Weiser, et al.
Frontiers in Medicine
|
October 16, 2023
A clinical evaluation of an <i>ex vivo</i> organ culture system to predict patient response to cancer therapy
Shay Golan, Vered Bar, Seth J Salpeter, et al.
Cancer Discovery
|
July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting
Chani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Nature Cancer
|
November 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures
Elinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, et al.
Cell
|
August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme, Yu Zhang, Liangliang Zhang, et al.
Cell
|
June 2, 2021
Microbial exposure during early human development primes fetal immune cells
Archita Mishra, Ghee Chuan Lai, Leong Jing Yao, et al.
Science (New York, N.Y.)
|
September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
The Journal of Experimental Medicine
|
March 18, 2024
Competitive fungal commensalism mitigates candidiasis pathology
Jarmila Sekeresova Kralova, Catalina Donic, Bareket Dassa, et al.
Nature Cancer
|
February 5, 2022
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
Adi Jacob Berger, Elinor Gigi, Lana Kupershmidt, et al.
Cell
|
September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.
Nature Cancer
|
February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Nancy Gavert, Yaara Zwang, Roi Weiser, et al.
Frontiers in Medicine
|
October 16, 2023
A clinical evaluation of an <i>ex vivo</i> organ culture system to predict patient response to cancer therapy
Shay Golan, Vered Bar, Seth J Salpeter, et al.
Cancer Discovery
|
July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting
Chani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Nature Cancer
|
November 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures
Elinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, et al.
Cell
|
August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme, Yu Zhang, Liangliang Zhang, et al.
Cell
|
June 2, 2021
Microbial exposure during early human development primes fetal immune cells
Archita Mishra, Ghee Chuan Lai, Leong Jing Yao, et al.
Science (New York, N.Y.)
|
September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Page
of 5